“…Interestingly, MS is recognized as a safe biomaterial for drug delivery applications due to their high surface area, large cargo capacity, and biocompatibility. − Nevertheless, their low targeting ability, poor accumulation in tumors and slow degradation are being questioned. − Therefore, to overcome these limitations, biodegradable nanohybrids have been proposed recently but they are far from addressing the site-selective tumor imaging and image guided tumor regression. − On the other hand, fluorescent graphene quantum dots (GQDs) have been widely used for tumor diagnosis and near-infrared (NIR) light responsive photothermal therapy in cancer nanomedicine. − These GQDs are highly promising for targeted tumor imaging due to their ultrasmall size, deep tissue visualization, and high aqueous dispersibility. However, the rapid clearance of GQDs is a critical issue so far. ,, Overall, MS and fluorescent GQDs have been recognized as promising platforms for diagnostics and cancer therapeutics individually. − Next, GQDs integrated mesoporous silica (MS) is a recent development for cancer diagnostics and therapeutics. ,− Especially, carbon nanodots incorporated mesoporous silica is recently reported for photothermal-immunotherapy but far from explaining about the image guided tumor regression with a precise follow-up …”